Nok Therapeutics, Inc.

Biotech Cranberry Twp., PA

About

Issuer

Entity type
Corporation
Jurisdiction
Florida
Sector
Biotech
Headquarters
Cranberry Twp., PA
Street
2009 Mackenzie Way
Zip
16066

Offering

Total offering
$1k
Amount sold
$1k
First sale
Jun 27, 2024
Min investment
$100
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
9 (4 accredited · 5 non-accredited)

How this filing compares

Ranked #19 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 0.0× the median.

Other Pennsylvania filings this week: Barrett Upton Tax-Efficient Income Fund LP, Caprock PSP V LP, Caprock Real Estate Opportunities I LP, Century Park Growth & Income Fund LP, Century Park Income Fund

Leadership

Robert Lewis — Executive Officer (also: Director, Promoter)

Also named on: Jabez Biosciences, Inc.

Brian Cogley — Executive Officer (also: Director)

Also named on: Jabez Biosciences, Inc.

Bruce Cassidy — Director

Also named on: Jabez Biosciences, Inc.

Martin Lewis — Director

Also named on: Jabez Biosciences, Inc.

Michael Lewis — Promoter

Also named on: Jabez Biosciences, Inc.

David Mehalick — Promoter

Also named on: Jabez Biosciences, Inc.

Filing details

Nok Therapeutics, Inc. filed a Form D with the SEC on March 26, 2026.

Other newest Biotech companies

Other newest companies in Pennsylvania